Bharat Biotech to scale up Covaxin production capacity to 700 million doses a year

Bharat Biotech on Tuesday announced expansion of its manufacturing capacity to produce as many as 700 million doses of Covaxin annually.

Covaxin has received Emergency Use Authorisations (EUA)s in several countries with another 60 in process.

EUAs have now been obtained from Mexico, Philippines, Iran, Paraguay, Guatemala, Nicaragua, Guyana, Venezuela, Botswana and Zimbabwe, among other countries.


Leave a Reply

Your email address will not be published. Required fields are marked *

Our YouTube ChannelOur Facebook PageOur Twitter PageOur LinkedIn PageOur Instagram PageOur Whatsapp NumberYour Idea